Trenbolone

ID: trenbolone

Aliases: trenbolone acetate, trenbolone enanthate, tren, 17beta-hydroxyestra-4,9,11-trien-3-one

Type: compound

Route/form: veterinary cattle implant in approved context; illicit human products are commonly injectable and not approved

Status: veterinary_approved_not_human

Evidence level: preclinical

Best data tier: direct preclinical; case-report/safety context

Support scope: non-human/mechanistic, review/regulatory

Source types: preclinical, regulatory_review, review, safety_review

Linked sources: 8

Broad outcomes: Cardiovascular / lipids / blood pressure, Fat loss / metabolic health, Hormones / fertility / sexual health, Muscle growth / performance / recovery, PEDs / AAS / thermogenics, Safety / regulatory

Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.

Targets / mechanism

• androgen receptor agonist
• progestogenic androgen
• non-aromatizing anabolic steroid

Optimization domains

• steroid
• muscle
• body composition
• androgen therapy
• doping
• cardiovascular

Research basis

• Veterinary implant use and animal studies support potent anabolic/androgenic activity.
• Rodent work links trenbolone to androgen-responsive transcription, satellite-cell responsiveness to IGF/FGF, hypertrophy, and satellite-cell number changes.
• The evidence base for body-composition claims is mostly veterinary and preclinical, not controlled human enhancement data.

Limits, risks, and missing evidence

• No approved human medical use is represented here; human physique use is extrapolated from veterinary and animal data.
• AAS-class suppression, fertility risk, blood pressure/lipids, cardiac remodeling, sleep/anxiety/neuropsychiatric effects, and product-identity risk dominate the safety frame.
• Animal signals about tissue selectivity or myostatin do not make trenbolone a safe or clean SARM-like substitute for testosterone.

Risk flags

• not approved for humans
• veterinary context
• endocrine suppression
• cardiovascular risk
• neuropsychiatric risk
• fertility risk

Linked papers, labels, and reviews

1. DailyMed label: SYNOVEX PLUS trenbolone acetate and estradiol benzoate implant
   regulatory_review / dailymed_synovex_trenbolone_label
   Veterinary cattle implant label; anchors trenbolone acetate as an approved animal growth-promoter context, not a human drug.
2. Tissue selectivity of the anabolic steroid, 17beta-hydroxyestra-4,9,11-trien-3-one in male Sprague Dawley rats
   preclinical / pubmed_trenbolone_tissue_selectivity_2010
   Direct trenbolone rat androgenic/anabolic tissue-selectivity source; non-human mechanism only.
3. Trenbolone prevents fat accumulation and improves bone mineral density in orchidectomized rats
   preclinical / pubmed_trenbolone_orchidectomized_rat_2012
   Direct trenbolone animal body-composition/bone source; does not establish human safety or dosing.
4. Anabolic-androgenic steroids: How do they work and what are the risks?
   review / pubmed_aas_risks_2023
   General AAS mechanism and risk review; used as class-level caution for nonmedical androgen/anabolic steroid entries.
5. Transcriptional regulation of myotrophic actions by testosterone and trenbolone on androgen-responsive muscle
   preclinical / pubmed_trenbolone_myotrophic_transcription_2014
   Rat androgen-responsive muscle transcription study comparing testosterone and trenbolone; supports mechanism without human safety inference.
6. Trenbolone alters the responsiveness of skeletal muscle satellite cells to fibroblast growth factor and insulin-like growth factor I
   preclinical / pubmed_trenbolone_satellite_cells_1989
   Rat satellite-cell/IGF-FGF responsiveness source; mechanistic support for muscle-growth claims, not a human performance trial.
7. Testosterone and trenbolone enanthate increase mature myostatin protein expression despite increasing skeletal muscle hypertrophy and satellite cell number in rodent muscle
   preclinical / pubmed_trenbolone_myostatin_satellite_cells_2017
   Rodent study linking androgen-induced hypertrophy with satellite-cell changes and mature myostatin protein; useful against simplistic myostatin narratives.
8. Anabolic-androgenic steroids among recreational athletes and cardiovascular risk
   safety_review / pubmed_aas_recreational_athletes_cv_review_2025
   Recent cardiovascular-risk review focused on recreational athlete AAS use; class-level safety source for nonmedical androgen entries.